Literature DB >> 18602440

Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy.

Chun Chieh Fan, Ming Chyi Huang, Hsing Cheng Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18602440     DOI： 10.1016/j.pnpbp.2008.06.006

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  4 in total

1.  Features of Adult Hyperammonemia Not Due to Liver Failure in the ICU.

Authors:  Amra Sakusic; Moldovan Sabov; Amanda J McCambridge; Alejandro A Rabinstein; Tarun D Singh; Kumar Mukesh; Kianoush B Kashani; David Cook; Ognjen Gajic
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

2.  L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.

Authors:  Cecilia Maldonado; Natalia Guevara; Alicia Silveira; Pietro Fagiolino; Marta Vázquez
Journal:  J Int Med Res       Date:  2017-04-20       Impact factor: 1.671

Review 3.  Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy.

Authors:  Christian Leporini; Caterina De Sarro; Caterina Palleria; Iolanda Caccavo; Brunella Piro; Rita Citraro; Giovambattista De Sarro
Journal:  Drug Saf       Date:  2022-09-16       Impact factor: 5.228

4.  Risk factors of elevated blood ammonia level in epilepsy patients treated with lamotrigine.

Authors:  Yiqian Chen; Jingzhen Chen; Xiaorong Zhuang; Xingyu Chen; Jianqi Zeng; Ru Wang; Jiayin Miao
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.